Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Intervalo de año de publicación
1.
Dig Liver Dis ; 52(8): 895-904, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32620521

RESUMEN

OBJECTIVE: Obesity-induced by high-fat diet (HFD) is associated with liver steatosis, oxidative stress and mitochondrial dysfunction, which can be eluded by the co-administration of the lipid metabolism modulator docosahexaenoic acid (DHA) and the antioxidant hydroxytyrosol (HT). METHODS: C57BL/6J mice fed a HFD were orally administered either with vehicle, DHA, HT or DHA+HT for 12 weeks. We measured parameters related to insulin resistance, serum lipid levels, liver fatty acid (FA) content and steatosis score, concomitantly with those associated with mitochondrial energy functions modulated by the transcriptional coactivator PGC-1a. RESULTS: HFD induced insulin resistance, liver steatosis with n-3 FA depletion, and loss of mitochondrial respiratory functions with diminished NAD+/NADH ratio and ATP levels compared with CD, with the parallel decrease in the expression of the components of the PGC-1α cascade, namely, PPAR-α, FGF21 and AMPK, effects that were not observed in mice subjected to DHA and HT co-administration. CONCLUSIONS: Data presented indicate that the combination of DHA and HT prevents the development of liver steatosis and the associated mitochondrial dysfunction induced by HFD, thus strengthening the significance of this protocol as a therapeutic strategy avoiding disease evolution into more irreversible forms characterised by the absence of adequate pharmacological therapy in human obesity.


Asunto(s)
Ácidos Docosahexaenoicos/farmacología , Hígado/metabolismo , Enfermedad del Hígado Graso no Alcohólico/prevención & control , Obesidad/prevención & control , Alcohol Feniletílico/análogos & derivados , Animales , Dieta Alta en Grasa/efectos adversos , Ácidos Docosahexaenoicos/administración & dosificación , Humanos , Resistencia a la Insulina , Metabolismo de los Lípidos/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos C57BL , Alcohol Feniletílico/administración & dosificación , Alcohol Feniletílico/farmacología , Distribución Aleatoria
2.
Artículo en Inglés | MEDLINE | ID: mdl-32007744

RESUMEN

The administration of iron induces liver oxidative stress and depletion of long-chain polyunsaturated fatty acids (LCPUFAs), n-6/n-3 LCPUFA ratio enhancement and fat accumulation, which may be prevented by antioxidant-rich extra virgin olive oil (AR-EVOO) supplementation. Male Wistar rats were subjected to a control diet (50 mg iron/kg diet) or iron-rich diet (IRD; 200 mg/kg diet) with alternate AR-EVOO for 21 days. Liver fatty acid (FA) analysis was performed by gas-liquid chromatography (GLC) after lipid extraction and fractionation, besides Δ-5 desaturase (Δ-5 D) and Δ6-D mRNA expression (qPCR) and activity (GLC) measurements. The IRD significantly (p < 0.05) increased hepatic total fat, triacylglycerols, free FA contents and serum transaminases levels, with diminution in those of n-6 and n-3 LCPUFAs, higher n-6/n-3 ratios, lower unsaturation index and Δ5-D and Δ6-D activities, whereas the mRNA expression of both desaturases was enhanced over control values, changes that were prevented by concomitant AR-EVOO supplementation. N-6 and n-3 LCPUFAs were also decreased by IRD in extrahepatic tissues and normalized by AR-EVOO. In conclusion, AR-EVOO supplementation prevents IRD-induced changes in parameters related to liver FA metabolism and steatosis, an effect that may have a significant impact in the treatment of iron-related pathologies or metabolic disorders such as non-alcoholic fatty liver disease.


Asunto(s)
Antioxidantes/administración & dosificación , Ácido Graso Desaturasas/genética , Hígado Graso/prevención & control , Hierro/efectos adversos , Linoleoil-CoA Desaturasa/genética , Aceite de Oliva/administración & dosificación , Animales , Antioxidantes/química , Antioxidantes/farmacología , Cromatografía de Gases , delta-5 Desaturasa de Ácido Graso , Modelos Animales de Enfermedad , Ácidos Grasos/análisis , Hígado Graso/inducido químicamente , Hígado Graso/epidemiología , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Masculino , Aceite de Oliva/química , Aceite de Oliva/farmacología , Ratas , Ratas Wistar
3.
Iatreia ; 18(1): 239-244, mar. 2005. ilus
Artículo en Español | LILACS | ID: lil-406189

RESUMEN

Hay un aumento de la utilización de los estudios imaginológicos en la evaluación de los pacientes con dolor abdominal agudo. El ultrasonido y la tomografía computarizada tienen gran valor en pacientes con sospecha de apendicitis aguda. La tomografía tiene una mayor sensibilidad y una alta especificidad. La mayor utilidad de ambos estudios se obtiene en el grupo de pacientes en quienes después de la evaluación inicial la probabilidad de apendicitis es indeterminada.Se puede concluir de los estudios clínicos que no hay pruebas del beneficio de la ecografía como estudio rutinario en pacientes con sospecha de apendicitis.


Diagnostic imaging is being increasingly used in the assessment of acute non-traumatic abdominal pain. Ultrasound and computed tomography investigations are of great value in patients with suspected appendicitis. Computed tomography seems to have a higher sensitivity than ultrasound and a high specificity. Both of them are most useful in patients who have an indeterminate probability of disease after the initial evaluation. From clinical studies it can be concluded that there is no proven benefit of routine ultrasound scanning of the appendix in patients with suspected acute appendicitis


Asunto(s)
Apendicitis , Tomografía , Ultrasonografía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...